Gyldenpharma
Oxford, GB · 1 known investors
Find your way into Gyldenpharma
Gylden Pharma develops proprietary dermal delivery platforms for therapeutic medicines, using titanium microneedles and programmable gold nanoparticles to enable rapid, precise drug delivery through the skin. The company focuses on oncology and infectious disease applications including tumor immunotherapy and vaccine development.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- GYLDEN PHARMA LIMITED
- Company number
- 09955881
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 18 Jan 2016
- Registered office
- 4 & 5 Dunmore Court Wootton Road, Abingdon, Oxfordshire, OX13 6BH
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Previous names
- EMERGEX VACCINES HOLDING LIMITED (2016–2024)
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 7 Aug 2026 · next due 21 Aug 2027
Current officers · 8
- Dr Poh Hui Chia — director, appointed 5 Jan 2024
- Tony Flanagan — director, appointed 9 Jul 2026
- David Clifford Jackson — director, appointed 17 Aug 2022
- Fabricio Klerynton Marchini — director, appointed 27 Aug 2026
- Storme Jo-Anne Moore-Thornicroft — director, appointed 18 Jan 2016
- Thomas William Rademacher — director, appointed 18 Jan 2016
- Finian Tan Seng Chin — director, appointed 3 Sept 2019
- Frank Tufaro — director, appointed 17 Aug 2022
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Gyldenpharma do?
- Gylden Pharma develops proprietary dermal delivery platforms for therapeutic medicines, using titanium microneedles and programmable gold nanoparticles to enable rapid, precise drug delivery through the skin. The company focuses on oncology and infectious disease applications including tumor immunotherapy and vaccine development.
- Who are Gyldenpharma's investors?
- Gyldenpharma's investors include Vickers Venture Partners.
- Where is Gyldenpharma headquartered?
- Gyldenpharma is headquartered in Oxford, GB.